We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

47 hedge funds and large institutions have $271M invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$58.3M
2
DM
Deerfield Management
New York
+$53.4M
3
Millennium Management
Millennium Management
New York
+$24.1M
4
Franklin Resources
Franklin Resources
California
+$13.2M
5
KCM
Kingdon Capital Management
New York
+$10.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$66.7M +$58.3M +2,169,900 New
DM
2
Deerfield Management
New York
$61.2M +$53.4M +1,988,990 New
Millennium Management
3
Millennium Management
New York
$27.6M +$24.1M +898,157 New
Franklin Resources
4
Franklin Resources
California
$15.1M +$13.2M +492,500 New
KCM
5
Kingdon Capital Management
New York
$12.4M +$10.8M +401,733 New
Ameriprise
6
Ameriprise
Minnesota
$11.7M +$10.2M +379,624 New
Jennison Associates
7
Jennison Associates
New York
$9.23M +$8.06M +300,000 New
VAM
8
Visium Asset Management
New York
$7.19M +$6.28M +233,625 New
WSA
9
Wall Street Associates
California
$6.92M +$6.05M +225,000 New
BFA
10
BlackRock Fund Advisors
California
$6.8M +$5.94M +221,029 New
Bank of New York Mellon
11
Bank of New York Mellon
New York
$5.73M +$5.01M +186,340 New
PI
12
Putnam Investments
Massachusetts
$5.06M +$4.42M +164,438 New
Wellington Management Group
13
Wellington Management Group
Massachusetts
$3.21M +$2.8M +104,210 New
DCM
14
Driehaus Capital Management
Illinois
$3.15M +$2.76M +102,552 New
CAM
15
Cormorant Asset Management
Massachusetts
$3.08M +$2.69M +100,000 New
BIT
16
BlackRock Institutional Trust
California
$2.9M +$2.54M +94,420 New
AWMDMG
17
Austin W. Marxe & David M. Greenhouse
New York
$2.45M +$2.14M +79,700 New
State Street
18
State Street
Massachusetts
$2.37M +$2.07M +77,199 New
JP Morgan Chase
19
JP Morgan Chase
New York
$2.37M +$2.07M +77,075 New
Morgan Stanley
20
Morgan Stanley
New York
$2.29M +$2M +74,377 New
EMFAT
21
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.8M +$1.58M +58,630 New
SONJCPFA
22
State of New Jersey Common Pension Fund A
New Jersey
$1.33M +$1.17M +43,400 New
Geode Capital Management
23
Geode Capital Management
Massachusetts
$1.3M +$1.14M +42,296 New
EA
24
Emerald Advisers
Pennsylvania
$1.27M +$1.11M +41,390 New
Vanguard Group
25
Vanguard Group
Pennsylvania
$1.14M +$994K +36,996 New
1
2

ASPX Hedge Fund Activity: Q1 2014 in Review

47 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q1 2014, worth a combined $271M.

Buyers outnumbered sellers: 47 funds opened new ASPX positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $58.3M.

  • 47 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $271M of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q1 2014.
  • 47 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q1 2014 and 0 closed out, a net change of +47 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2014 was Fidelity Investments, an estimated $58.3M added.

Based on aggregated 13F filings for Q1 2014.